Healthcare provider profile · identity verified

Michael J Govi, MD

Family Practice · PITTSBURGH, PA · NPI 1447299052

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	472	134
Amlodipine Besylate	Amlodipine Besylate	379	108
Levothyroxine Sodium	Levothyroxine Sodium	342	77
Lisinopril	Lisinopril	321	91
Losartan Potassium	Losartan Potassium	304	68
Omeprazole	Omeprazole	297	92
Sertraline Hcl	Sertraline Hcl	195	49
Pantoprazole Sodium	Pantoprazole Sodium	191	35
Simvastatin	Simvastatin	171	37
Metoprolol Succinate	Metoprolol Succinate	160	49
Gabapentin	Gabapentin	151	37
Fluticasone Propionate	Fluticasone Propionate	150	57
Metoprolol Tartrate	Metoprolol Tartrate	140	26
Albuterol Sulfate Hfa	Albuterol Sulfate	136	48
Eliquis	Apixaban	136	30
Hydrochlorothiazide	Hydrochlorothiazide	132	37
Furosemide	Furosemide	114	25
Famotidine	Famotidine	110	40
Metformin Hcl	Metformin Hcl	108	34
Tamsulosin Hcl	Tamsulosin Hcl	105	32
Rosuvastatin Calcium	Rosuvastatin Calcium	102	31
Citalopram Hbr	Citalopram Hydrobromide	96	15
Pravastatin Sodium	Pravastatin Sodium	95	27
Potassium Chloride	Potassium Chloride	92	27
Duloxetine Hcl	Duloxetine Hcl	83	24
Trulicity	Dulaglutide	82	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	80	22
Trazodone Hcl	Trazodone Hcl	79	18
Valacyclovir	Valacyclovir Hcl	77	13
Spironolactone	Spironolactone	76	suppressed
Xarelto	Rivaroxaban	67	14
Jardiance	Empagliflozin	66	13
Cephalexin	Cephalexin	63	40
Myrbetriq	Mirabegron	63	suppressed
Atenolol	Atenolol	62	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	61	11
Lorazepam	Lorazepam	61	27
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	59	24
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	55	13
Fluoxetine Hcl	Fluoxetine Hcl	54	15
Clonazepam	Clonazepam	53	15
Warfarin Sodium	Warfarin Sodium	52	11
Azelastine Hcl	Azelastine Hcl	50	15
Clopidogrel	Clopidogrel Bisulfate	50	14
Meloxicam	Meloxicam	50	16
Triamcinolone Acetonide	Triamcinolone Acetonide	49	32
Bupropion Hcl Sr	Bupropion Hcl	48	14
Ozempic	Semaglutide	48	suppressed
Alprazolam	Alprazolam	46	13
Prednisone	Prednisone	46	38
Alendronate Sodium	Alendronate Sodium	45	14
Allopurinol	Allopurinol	44	13
Carvedilol	Carvedilol	44	11
Mirtazapine	Mirtazapine	44	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	43	35
Venlafaxine Hcl Er	Venlafaxine Hcl	43	suppressed
Synthroid	Levothyroxine Sodium	42	11
Oxycodone Hcl	Oxycodone Hcl	41	suppressed
Tramadol Hcl	Tramadol Hcl	41	16
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	40	13
Montelukast Sodium	Montelukast Sodium	40	14
Amoxicillin	Amoxicillin	39	32
Bupropion Hcl	Bupropion Hcl	39	suppressed
Glipizide Er	Glipizide	39	11
Bisoprolol Fumarate	Bisoprolol Fumarate	38	suppressed
Ventolin Hfa	Albuterol Sulfate	38	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	36	suppressed
Clotrimazole	Clotrimazole	35	13
Valsartan	Valsartan	33	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	32	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	31	suppressed
Donepezil Hcl	Donepezil Hcl	29	suppressed
Humalog Kwikpen U-100	Insulin Lispro	29	suppressed
Ondansetron Hcl	Ondansetron Hcl	29	suppressed
Glimepiride	Glimepiride	28	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	27	25
Finasteride	Finasteride	26	suppressed
Meclizine Hcl	Meclizine Hcl	26	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	25	suppressed
Naproxen	Naproxen	25	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	24	suppressed
Ketoconazole	Ketoconazole	24	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	24	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	24	11
Celecoxib	Celecoxib	23	suppressed
Mounjaro	Tirzepatide	23	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	23	suppressed
Azithromycin	Azithromycin	22	19
Paroxetine Hcl	Paroxetine Hcl	22	suppressed
Methocarbamol	Methocarbamol	20	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	19	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	19	suppressed
Ezetimibe	Ezetimibe	19	suppressed
Ibuprofen	Ibuprofen	18	suppressed
Ipratropium Bromide	Ipratropium Bromide	18	suppressed
Nystatin	Nystatin	18	suppressed
Ondansetron Odt	Ondansetron	18	suppressed
Rybelsus	Semaglutide	18	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	18	suppressed
Baclofen	Baclofen	17	suppressed
Breo Ellipta	Fluticasone/Vilanterol	17	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	17	suppressed
Pregabalin	Pregabalin	17	suppressed
Metformin Hcl Er	Metformin Hcl	16	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	16	suppressed
Mupirocin	Mupirocin	15	suppressed
Bupropion Xl	Bupropion Hcl	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Indapamide	Indapamide	14	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Raloxifene Hcl	Raloxifene Hcl	14	suppressed
Lamotrigine	Lamotrigine	13	suppressed
Sure Comfort Pen Needle	Pen Needle, Diabetic	13	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Jantoven	Warfarin Sodium	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	11	11
Fenofibrate	Fenofibrate Nanocrystallized	11	suppressed
Hydralazine Hcl	Hydralazine Hcl	11	suppressed
Lidocaine Hcl Viscous	Lidocaine Hcl	11	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	11	suppressed
Rizatriptan	Rizatriptan Benzoate	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error